Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Conditions
- HER2-positive Breast Cancer
- HER2 Gene Mutation
- HER-2 Gene Amplification
- HER2 Positive Gastric Cancer
- Salivary Gland Cancer
- Salivary Gland Tumor
- Salivary Gland Carcinoma
- Salivary Gland Neoplasms
- Lung Cancer
- Colo-rectal Cancer
- Rare Diseases
- Solid Tumor
- Recurrent Gastric Cancer
- Recurrent Colon Cancer
- Recurrent Breast Cancer
- Head and Neck Cancer
- Head and Neck Carcinoma
- Bladder Cancer
- Cervical Cancer
- Liver Cancer
- Bile Duct Cancer
- Urologic Cancer
- Pancreatic Cancer
- Prostate Cancer
- Recurrent Prostate Cancer
- Rectal Cancer
- Recurrent Ovarian Carcinoma
- Recurrent Renal Cell Cancer
- Rectal Cancer Stage II
- Rectal Cancer Stage I
- Rectal Cancer Stage III
- Skin Cancer
- Mouth Cancer
- Lip Cancer Stage I
- Tongue Cancer
- Breast Neoplasm Malignant Primary
- Larynx Cancer
- Tonsil Cancer
- Palate Cancer
- Mucoepidermoid Carcinoma
- Primary Peritoneal Carcinoma
- Mucinous Adenocarcinoma Gastric
- Mucinous Breast Cancer Recurrent
- Cholangiocarcinoma
Interventions
Sponsor
Klus Pharma Inc.